RecruitingNCT07024836

PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment


Sponsor

University College, London

Enrollment

430 participants

Start Date

May 22, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study is part of a broader programme of work to develop and pilot a randomised-controlled trial of new tests to identify people who will benefit most from preventive treatment for tuberculosis (TB). The aim of the current study is to explore factors affecting patient decisions to start preventive treatment. The specific objectives are to understand how patients make decisions about preventive treatment initiation for TB (stage 1); and to design and conduct a "discrete choice experiment" survey to further evaluate preferences (stage 2).


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Adults (aged ≥18 years) who have been tested for latent TB infection in routine clinical services, or are eligible for testing. Eligible people for testing include migrants from countries with high TB incidence (entered UK within 5 years), people with recent contact with a person with TB disease, and people eligible for LTBI screening prior to starting immunosuppression or through occupational health testing.

Exclusion Criteria1

  • Unable to provide informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Whittington Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07024836


Related Trials